Stentmaker SMT to file draft papers for ₹2,000 crore IPO

stajanand Mediod Technal ogien SMT), a leading domes the manifacturer of cardiac stents, is set to füer its drah th the market re sor net gronth for a 11,500-2,000 crore initial public offering (IPO)
The IPO is being led by Mortfal Uimal, Avendus. Nerama and ISIC, andinginvestors such as Semasa Capital, Kotak and Mongan Randey nimading their staho the people cited abow-said
“The issue wall have only an offer fur-sale component and the draft papers are expected to bend in Joly witha poomtial listinghy the end of this your, the second perсемей.
This tocans that the will te any fresh capital fur MT and all pro cools from the share will go only to the selling shareholders.
While Avendus. HSBC and SMT comment, others did not declined to comment, ofera did not Imgurdiately respond in This would mark SMT second attempt to go public after it shebests 2021 IPO quan. SMT, which holla 25-30% market share in Indi drug-eluting stend segment, finit flextfve an IPO in September 2721 Inrabeamund 1500 crore, pruing both an OFSanila prim pemary e. The funds were earmarked for repaying debt and supporting theworking capital seeds-fit f alarm, Vascular Innovations Laprimary
The IPO was later put on hold. Instead, SMT raved around crore from Katak’s Pre-IPO Opportunities Found in 2005